Radiation-chemotherapy for carcinoma of the oesophagus
1998

Radiation-Chemotherapy for Oesophageal Cancer

Sample size: 121 publication Evidence: moderate

Author Information

Author(s): P Price, PJ Hoskin, T Hutchinson, S Stenning

Primary Institution: UK Medical Research Council

Hypothesis

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus?

Conclusion

Radiation-chemotherapy has not yet been established as standard therapy for the radical non-surgical management of carcinoma of the oesophagus in the UK.

Supporting Evidence

  • The Intergroup trial showed a large difference in 5-year survival between treatment arms.
  • The radiation-chemotherapy arm had a median survival of 12.5 months compared to 8.9 months for radiotherapy alone.
  • Acute toxicities were more pronounced in the radiation-chemotherapy arm.

Takeaway

Doctors are trying to find the best way to treat a type of throat cancer using a mix of radiation and medicine, but they aren't sure if it's the best choice yet.

Methodology

The study involved randomized trials comparing radiotherapy alone to radiotherapy with synchronous chemotherapy.

Potential Biases

There may be biases due to differences in disease stage and type of cancer between the groups.

Limitations

The trials had small sample sizes and differences in patient demographics between treatment groups.

Participant Demographics

Patients with stage II squamous carcinoma of the oesophagus and Tl-T3 NO-N1 carcinomas.

Statistical Information

P-Value

0.16

Confidence Interval

95% confidence intervals for 2-year survival

Statistical Significance

p=0.16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication